MorphoSys AG at JPMorgan Healthcare Conference Transcript
Great. Good afternoon. I'm James Gordon, JPMorgan European pharma and biotech analyst. And today, I've got the pleasure of introducing the MorphoSys presentation. And you're going to hear from MorphoSys' CEO, Jean-Paul Kress.
And we're going to have about a 20-minute presentation, and then we're going to have about 20 minutes of Q&A. And you'll be able to ask questions either by raising your hand and we can pass you a microphone, or you can use the JPMorgan app that you're probably now quite familiar with, and I can ask your question for you.
So with that said, thanks very much for joining us today, Jean-Paul.
Thank you, James. Thank you very much. Pleasure to be here in person to share with you our progress at MorphoSys and our many opportunities. I will start by showing the forward-looking statements slide, which I'm not sure if it works. Oops, that's the thing.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
